JP2020526530A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020526530A5 JP2020526530A5 JP2020500810A JP2020500810A JP2020526530A5 JP 2020526530 A5 JP2020526530 A5 JP 2020526530A5 JP 2020500810 A JP2020500810 A JP 2020500810A JP 2020500810 A JP2020500810 A JP 2020500810A JP 2020526530 A5 JP2020526530 A5 JP 2020526530A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- seq
- lipid
- peptide antigens
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762530498P | 2017-07-10 | 2017-07-10 | |
| US62/530,498 | 2017-07-10 | ||
| PCT/CA2017/051336 WO2019010560A1 (en) | 2017-07-10 | 2017-11-09 | PHARMACEUTICAL COMPOSITIONS, METHODS OF PREPARATION USING LIPID VESICLE PARTICLES OF A DEFINED SIZE, AND USES THEREOF |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020526530A JP2020526530A (ja) | 2020-08-31 |
| JP2020526530A5 true JP2020526530A5 (https=) | 2020-12-10 |
| JP7409594B2 JP7409594B2 (ja) | 2024-01-09 |
Family
ID=65000992
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020500810A Active JP7409594B2 (ja) | 2017-07-10 | 2017-11-09 | 医薬組成物、規定のサイズの脂質ベシクル粒子を使用する調製物のための方法、及びそれらの使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20200230057A1 (https=) |
| EP (1) | EP3651733A4 (https=) |
| JP (1) | JP7409594B2 (https=) |
| CN (1) | CN111093623A (https=) |
| AU (1) | AU2017423053A1 (https=) |
| CA (1) | CA3069019A1 (https=) |
| WO (1) | WO2019010560A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019178677A1 (en) * | 2018-03-20 | 2019-09-26 | Immunovaccine Technologies Inc. | Methods and compositions for targeted delivery of active agents and immunomodulatory agents to lymph nodes |
| KR20210086612A (ko) | 2018-09-04 | 2021-07-08 | 트레오스 바이오 리미티드 | 펩타이드 백신 |
| CN113966227B (zh) | 2019-02-15 | 2025-10-10 | 克利夫兰诊所基金会 | 疫苗佐剂以及制剂 |
| EP3954382A4 (en) * | 2019-04-05 | 2022-12-21 | Sumitomo Pharma Co., Ltd. | WATER SOLUBLE ADJUVANT AND COMPOSITION CONTAINING IT |
| EP3976092A1 (en) * | 2019-05-25 | 2022-04-06 | Infectious Disease Research Institute | Composition and method for spray drying an adjuvant vaccine emulsion |
| AU2021349286B2 (en) * | 2020-09-24 | 2025-03-06 | Nant Holdings Ip, Llc | Vaccine compositions for mucosal immune response |
| US20230355526A1 (en) * | 2020-09-28 | 2023-11-09 | Immunovaccine Technologies Inc. | Lipid compositions comprising polynucleotide antigens |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2906110A (en) * | 1959-09-29 | Silencing attachment for seamless | ||
| US20060035853A1 (en) | 2004-01-07 | 2006-02-16 | Biomedical Research Models, Inc. | Methods for tailoring the immune response to an antigen or immunogen |
| ES2524699T3 (es) | 2008-06-05 | 2014-12-11 | Immunovaccine Technologies Inc. | Composiciones que comprenden liposomas, un antígeno, un polinucleótido y un vehículo que comprende una fase continua de una sustancia hidrófoba |
| JP5429710B2 (ja) | 2009-03-30 | 2014-02-26 | 独立行政法人放射線医学総合研究所 | 治療薬剤の標的部位への集積及び放出を追跡可能な治療薬剤含有リポソームおよびその製造方法 |
| KR101102834B1 (ko) * | 2010-02-24 | 2012-01-05 | 충남대학교산학협력단 | 신규한 리포좀 제조 방법 및 장치 |
| CU20100144A7 (es) | 2010-07-06 | 2012-06-21 | Centro Inmunologia Molecular | Composiciones vacunales a base de sticholisina encapsulada en liposomas |
| US20140199233A1 (en) | 2011-05-11 | 2014-07-17 | The Regents Of The University Of California | Enhanced Growth Inhibition of Osteosarcoma by Cytotoxic Polymerized Liposomal Nanoparticles Targeting the Alcam Cell Surface Receptor |
| JP6240077B2 (ja) * | 2011-10-06 | 2017-11-29 | イムノバクシーン・テクノロジーズ・インコーポレイテッドＩｍｍｕｎｏｖａｃｃｉｎｅ Ｔｅｃｈｎｏｌｏｇｉｅｓ Ｉｎｃ． | Ｔｌｒ２を活性化するか、またはその活性を増加させるアジュバントを含むリポソーム組成物およびその使用 |
| EP3572071A1 (en) * | 2011-10-21 | 2019-11-27 | Jazz Pharmaceuticals Research LLC | Lyophilized liposomes |
| CA2853685C (en) * | 2011-11-04 | 2019-09-03 | Nitto Denko Corporation | Single use system for sterilely producing lipid-nucleic acid particles |
| RU2677658C2 (ru) | 2012-07-05 | 2019-01-18 | Тайвэн Липосом Ко, Лтд. | Способы лечения артрита |
| US9693958B2 (en) | 2013-03-15 | 2017-07-04 | Cureport, Inc. | Methods and devices for preparation of lipid nanoparticles |
| AU2016309847B2 (en) * | 2015-08-19 | 2019-10-31 | Xiamen Ginposome Pharmaceutical Co., Ltd. | Liposomes with ginsenoside as membrane material and preparations and use thereof |
| EP3377099A4 (en) | 2015-11-18 | 2019-07-24 | ImmunoVaccine Technologies Inc. | ADJUVANT SYSTEMS AND WATER-FREE VAPOR COMPOSITION OF ONE POLYI: C-POLYNUCLEOTIDADJUVANS AND ADJUVANS ON LIPID BASE |
| WO2017097196A1 (zh) | 2015-12-08 | 2017-06-15 | 正大天晴药业集团股份有限公司 | 脂质体的制备方法 |
-
2017
- 2017-11-09 CN CN201780094129.5A patent/CN111093623A/zh active Pending
- 2017-11-09 CA CA3069019A patent/CA3069019A1/en active Pending
- 2017-11-09 JP JP2020500810A patent/JP7409594B2/ja active Active
- 2017-11-09 US US16/629,780 patent/US20200230057A1/en not_active Abandoned
- 2017-11-09 EP EP17917340.6A patent/EP3651733A4/en not_active Withdrawn
- 2017-11-09 AU AU2017423053A patent/AU2017423053A1/en not_active Abandoned
- 2017-11-09 WO PCT/CA2017/051336 patent/WO2019010560A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020526530A5 (https=) | ||
| JP7604519B2 (ja) | Ｒｎａコンストラクトおよびその使用 | |
| Riccardi et al. | Liposomes, transfersomes and niosomes: production methods and their applications in the vaccinal field | |
| Nordly et al. | Immunity by formulation design: induction of high CD8+ T-cell responses by poly (I: C) incorporated into the CAF01 adjuvant via a double emulsion method | |
| US8926994B2 (en) | Mesoporous silicon particles for the presentation of tumor antigens and adjuvant for anti-cancer immunity | |
| Chattopadhyay et al. | Nanoparticle vaccines adopting virus-like features for enhanced immune potentiation | |
| Li et al. | Rational design of polymeric hybrid micelles to overcome lymphatic and intracellular delivery barriers in cancer immunotherapy | |
| US20220362388A1 (en) | Rna formulations suitable for therapy | |
| Smith et al. | Applications of nanotechnology for immunology | |
| US10378018B2 (en) | RNA-based compositions and adjuvants for prophylactic and therapeutic treatment | |
| KR101308591B1 (ko) | 양이온성 지질을 포함하는 음이온성 약물 전달체 및 그 제조방법 | |
| CN103372217B (zh) | 聚合物纳米载体制剂及其制备方法和应用 | |
| JP2014522842A5 (https=) | ||
| Avila et al. | Gene delivery and immunomodulatory effects of plasmid DNA associated with Branched Amphiphilic Peptide Capsules | |
| JP2018065821A5 (https=) | ||
| CN105980447A (zh) | 二氧化硅囊泡的合成方法及其用途 | |
| JP7409594B2 (ja) | 医薬組成物、規定のサイズの脂質ベシクル粒子を使用する調製物のための方法、及びそれらの使用 | |
| WO2023000403A1 (zh) | 一种新型冠状病毒亚蛋白纳米疫苗及其制备方法和应用 | |
| WO2016062227A1 (zh) | 聚乙二醇化磷脂为载体的胶束多肽疫苗 | |
| Mody et al. | Freeze-drying of ovalbumin loaded mesoporous silica nanoparticle vaccine formulation increases antigen stability under ambient conditions | |
| Marin et al. | Next generation polyphosphazene immunoadjuvant: Synthesis, self-assembly and in vivo potency with human papillomavirus VLPs-based vaccine | |
| US20240398918A1 (en) | Design of immunostimulatory protein-core spherical nucleic acids | |
| WO2026007297A1 (zh) | 一种高效跨粘膜障碍并诱导粘膜免疫强化的多功能仿生递送平台的制备方法及应用 | |
| Palumbo et al. | Bacterial invasin: structure, function, and implication for targeted oral gene delivery | |
| CN102369242B (zh) | 包含疏水化聚氨基酸的聚离子复合物及其用途 |